To determine the pre-emptive effect of Gabapentin on acute and chronic post-operative pain after spinal surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2007-005996-32-GB

Enrollment

Registered

2008-05-02

Start date

2008-06-25

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute and chronic back pain after surgery

Interventions

Trade Name: Gabapentin Product Name: Gabapentin Pharmaceutical Form: Capsule* Concentration type: not less then Concentration number: 30

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I - 3 patients who underwent spinal operation in the age group of 18 - 75 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Already on Gabapentin or allergy to Gabapentin or morphine

Design outcomes

Primary

Measure	Time frame
Main Objective: To determine the pre-emptive effect of Gabapentin on patients who had spinal surgery;Secondary Objective: ; Primary end point(s): Pain score for comparison of both groups. Analgesia - Verbal Rates Score (VRS) - LANSS assessment for neuropathic pain	—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026